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Abstract
Stimulating lymphocytes with Ifn-c, anti-CD3, and interleukin-2 promotes the proliferation of a cell population coexpressing
T-lymphocyte surface antigens such as CD3, CD8a, and CD25 as well as natural killer cell markers such as NK1.1, CD49, and
CD69. These cells, referred to as cytokine-induced killer cells (CIKs), display cytotoxic activity against tumour cells, even
without prior antigen presentation, and offer a new cell-based approach to the treatment of malignant diseases. Because
CIKs are limited in vivo, strategies to optimize in vitro culture yield are required. In the last 10 years, mesenchymal stem cells
(MSCs) have gathered considerable attention. Aside from their uses in tissue engineering and as support in haematopoietic
stem cell transplantations, MSCs show notable immunomodulatory characteristics, providing further possibilities for
therapeutic applications. In this study, we investigated the influence of murine MSCs on proliferation, phenotype, vitality,
and cytotoxicity of murine CIKs in a coculture system. We found that CIKs in coculture proliferated within 7 days, with an
average growth factor of 18.84, whereas controls grew with an average factor of 3.7 in the same period. Furthermore, higher
vitality was noted in cocultured CIKs than in controls. Cell phenotype was unaffected by coculture with MSCs and, notably,
coculture did not impact cytotoxicity against the tumour cells analysed. The findings suggest that cell–cell contact is
primarily responsible for these effects. Humoral interactions play only a minor role. Furthermore, no phenotypical MSCs
were detected after coculture for 4 h, suggesting the occurrence of immune reactions between CIKs and MSCs. Further
investigations with DiD-labelled MSCs revealed that the observed disappearance of MSCs appears not to be due to
differentiation processes.
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Introduction
Stimulating lymphocytes with interferon-c (Ifn-c), anti-CD3,
and interleukin (IL)-2 leads to the selection and proliferation of
cells expressing T-lymphocyte surface antigens such as CD3,
CD8a, and CD25 as well as natural killer (NK) cell markers such
as NK1.1, CD49, and CD69 [1–3]. These cells, referred to as
cytokine-induced killer cells (CIKs), mediate major histocompat-
ibility complex-unrestricted cytotoxic activity against target cells
even without prior antigen presentation [1]. Several studies have
attested to the potency of CIKs in lysing tumour cells [4–6], and
CIKs are promising new options in the treatment of malignant
diseases.
Peripheral blood lymphocytes contain only ,5% CIKs [3]. For
efficient treatment, CIKs must therefore be expanded in vitro
before transplantation back into patients. Many efforts have been
made to optimize the yield of in vitro CIK enrichment. One
approach is to use alternative cytokines for stimulation, such as IL-
7 or IL-12 instead of IL-2. The replacement of IL-2 by IL-12
improves cytotoxicity, but simultaneously lowers proliferation
rates. The use of IL-7 has no distinct advantages [2,7]. Use of
bispecific antibodies, such as anti-CD3/anti-CA125 or anti-CD3/
anti-Her2, has been found to induce CIK-mediated lysis of
otherwise CIK-resistant ovarian carcinoma cells; however, this
approach does not yield increased proliferation rates [8]. Another
study reported that the anti-tumour activity of CIKs can be
improved through transfection with oncolytic viruses [9] or genes
for tumour-specific receptors [10]. Cocultures of CIKs with
dendritic cells have yielded increased CIK proliferation and
cytotoxicity, as well [11]. Even higher cytotoxicities are observed
when idiotype-pulsed dendritic cells are used [12]. Against this
background, the present study investigated the interactions
between CIKs and mesenchymal stem cells (MSCs) in a coculture
system.
MSCs are multipotent adult stem cells that physiologically
reside in tissues such as bone marrow [13], adipose tissue [14],
amniotic fluid [15], connective tissue [16], and many others [17–
20]. Owing to varying stem cell niches, MSCs are a heterogeneous
cell population in terms of differentiation potential, proliferation
capacity, phenotype, and other characteristics [21,22]. Aside from
the niche conditions, various isolation and cultivation protocols,
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donor sex and age, choice of media, and especially species-related
distinctions contribute to the remarkable heterogeneity of MSCs
[21]. This heterogeneity has led to a considerably incomplete
understanding of MSCs what is reflected in an inconsistent
nomenclature [21] and in partially contradictory characterizations
of MSCs. The International Society for Cell Therapy (ISCT) has
therefore proposed criteria for characterization of human MSCs,
including adherence to plastic surfaces, the capability to differen-
tiate into osteoblasts, adipocytes, and chondrocytes, and pheno-
typical characters [28]. The identification by phenotyping is not
trivial. Indeed, a variety of phenotypical characteristics appears in
the ISCT criteria and the literature; however, none of these
markers is unique for MSCs. Aside from preanalytical challenges
and species-related distinctions, the difficulty in identification is
certainly due to the aforementioned heterogeneity of MSCs.
Therefore, a combination of positive and negative markers should
be used to characterize MSCs.
Working with MSCs from different species complicates
identification further. Although many of the criteria proposed
for human MSCs are also applicable to the murine system,
substantial distinctions among MSCs of different species have been
reported [31,50]. Therefore, the murine MSCs used in this study
were characterized under consideration of the ISCT criteria and
additionally under consideration of publications dealing with
murine MSCs. The following criteria were considered: adherence
to plastic surfaces [25,26,27]; spindle-shaped, fibroblast-like
morphology [27,54]; growth in the form of colony-forming units
(CFUs) and capability of differentiation into osteoblasts [21]; and
phenotypical features [15,28,44–46,51–53]. Many previous pub-
lications using the identical protocol for MSC isolation have also
shown adipocyte and chondrocyte differentiation [13].
MSCs show many immunomodulatory characteristics, which
makes them a promising tool for use in therapies. For example,
human MSCs display MHC-unrelated suppression of T-lympho-
cyte proliferation; this effect has been observed on both naive as
well as mature T-lymphocytes. Thereby, T-lymphocytes do not
become apoptotic or anergic, as they are stimulable after removal
from the MSC milieu [31]. The proliferation of NK cells [32], B
cells [33], and dendritic cells [30] is also reportedly suppressed by
MSCs.
The immunomodulatory effects of MSCs are multifaceted and,
to some extent, even contrary. Many reports have highlighted the
immunosuppressive characteristics of MSCs. Go¨therstro¨m [30],
for example, reported the case of a 9-year-old boy who developed
acute graft-versus-host disease (GvHD) IV after receiving haema-
topoietic stem cell transplant from a matched unrelated donor for
treatment of leukaemia and who was resistant to established forms
of immunosuppression. Infusions of haploidentical MSCs derived
from the patient’s mother reversed the GvHD. Eight additional
patients with steroid refractory GvHD III–IV were treated with
MSC infusions and showed no side effects. Six of the eight patients
displayed complete response.
In contrast, other groups have reported that MSCs do not show
constitutional immunosuppressive or antiproliferative effects [31–
36]. These studies postulate a more differentiated point of view
that requires consideration of a multitude of conditions and
external influences, such as the stage of activation of cocultured
lymphocytes/NK cells or the ratio between MSCs and lympho-
cytes/NK cells. In this study, we investigated the influence of
murine MSCs on proliferation, phenotype, vitality, and cytotox-
icity of murine CIKs in a coculture system.
Materials and Methods
Ethics Statement
Mice used for isolation of splenocytes and bone marrow cells
were raised and housed in the animal facilities of the Faculty of
Medicine, University of Leipzig, according to European (Council
Directive 86/609/EEC) and German (Tierschutzgesetz) guidelines
for the welfare of experimental animals. The killing of animals was
presented to and approved by local authorities (Landesdirektion
Sachsen, TV T13/09).
Isolation and Cultivation of MSCs and DiD Staining
8- to 12-week-old C57/black 6 mice were killed using CO2, and
their femora and tibiae were removed and cleaned of skin and
muscle. According to the method of Dobson [25], the proximal
and distal ends of the murine femora and tibiae were removed, the
bones were inserted into Eppendorf tubes, and bone marrow was
obtained after centrifugation (10 min, 2506g). Bone marrow cells
were then collected in medium (RPMI 1640, 10% foetal calf
serum [FCS], 1% 1 M HEPES, 0.5% gentamycin, and 0.1%
mercaptoethanol; all purchased from Gibco, Invitrogen, Ger-
many). To obtain adherent cells, 5.46107 cells per T25 flask
(Greiner, BIO, Germany) were plated and cultured at 5% CO2
and 37uC. After 72 h, the supernatants, and therefore all
suspended cells, were discarded, and the medium was replaced.
On day 7 (cells nearly reached confluence), the cells were either
used for coculture with CIKs or were harvested for flow
cytometry.
The medium in some of the flasks was removed after 6 days and
replaced with 3.5 ml of fresh medium supplemented with DiD
staining solution (5 ml DiD/ml; Vybrant staining solution,
Invitrogen). After incubation with the staining solution for
30 min, the supernatant was discarded, and the cells were washed
with phosphate-buffered saline (PBS). Finally, fresh medium was
added and DiD-labelled cells were placed in the incubator until
use the following day.
Isolation and Cultivation of Control CIKs
8- to 12-week-old C57/black 6 mice were killed using CO2, and
their spleens were removed and pressed through a filter (pore size,
100 mm; Greiner BIO One) into Petri dishes containing PBS
(supplemented with 1% FCS and 0.5% gentamycin [Gibco,
Invitrogen]). Cells were washed with PBS, incubated with
erythrocyte lysis buffer (Gibco, Invitrogen) for 1 min, and washed
again before medium was added (RPMI 1640, 10% FCS, 1% 1 M
HEPES, 0.5% gentamycin, and 0.1% mercaptoethanol [Gibco,
Invitrogen]). Cells were counted using trypan blue and plated at a
concentration of 26106 cells per millilitre of culture in T75 cell
culture flasks (Greiner, BIO). Recombinant murine (rm)-Ifn-c
(1.000 U/ml; Immunotools, Germany) was added, and cells were
incubated (5% CO2 and 37uC). After 1 day, 50 ng/ml anti-CD3
antibodies (OKT3, BD-Pharma) and 300 U/ml rm-IL-2 (Im-
munotools) were added. Cells were passaged and counted on days
3, 7, 11, 14, and 17, and medium as well as rm-IL-2 were replaced
in appropriate amounts.
CIK/MSC Cocultures
On day 7, supernatants from the nearly confluent MSC flasks
(containing 0.86106 MSCs) were discarded, and 3.6 million 7-
day-old allogeneic CIKs, fresh medium, and appropriate amounts
of rm-IL-2 were added. On days 11 and 14, two-thirds or half of
the medium, and therefore that number of suspended cells, were
removed and replaced with fresh medium and an adequate
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amount of rm-IL-2 (300 U/ml) such that cocultured CIKs (cCIKs)
were split at a ratio 1:3 or 1:2, respectively.
CIKs in MSC-conditioned Medium
MSC supernatants were removed on day 7 and centrifuged to
ensure that no cells were left in the supernatant media. Then, two-
thirds of the cell suspension from 7-day-old CIK cultures, and thus
two-thirds of the CIKs were withdrawn and replaced with MSC-
conditioned medium such that CIKs were split at a ratio of 1:3.
Rm-IL-2 was substituted in the appropriate amount (300 U/ml
conditioned medium). The same procedure was carried out on
days 11 and 14.
Cultivation of Target Cells
Cells of an adherent fibrosarcoma cell lineage (Wehi 164 S;
DSMZ, Braunschweig, Germany) were plated (RPMI medium
1640, 10% FCS, and 1% penicillin/streptomycin, purchased from
Gibco, Invitrogen) at a density of 1.5 million cells/75 cm2 and
passaged every 2–3 days.
Flow Cytometry
CIKs and MSCs were harvested, transferred into PBS, and
incubated with Fc-solution (Beckman Coulter) for 5 min at 4uC to
prevent unspecific antibody binding. During the incubation with
Fc-blocking reagent, antibodies were placed in fluorescence-
activated cell sorter (FACS) tubes (Greiner, BIO). The following
antibodies, purchased from Beckman Coulter (final concentrations
in brackets), were used: CD3-FITC (1:100), CD4-PE (1:250),
CD8a-PE (1:250), CD11b-PE (1:160), CD19-PE (1:250), CD25-
PE (1:250), CD45-PE (1:250), CD49-PE (1:250), NK1.1-PE (1:60),
CD69-PE (1:250), HamIgG-FITC-isotype-control (1:250), and
RatIgG2a-PE-isotype-controll (1:250). In addition, CD34-PE
(Caltaq, 1:100), CD44-AF488 (Biozol, 1:250), CD73-PE (Biozol,
1:100), CD90 (Thy1.2)-FITC (Miltenyi, 1:100), and CD166
(Antiko¨rper-online, 1:100).
After incubation for 5 min, Fc-blocked cells were added to the
antibody-containing FACS tubes, incubated for 20 min at 4uC,
and washed with PBS. Then, 7-aminoactinomycin-D (7-AAD;
1:100, Beckman Coulter) stain was added, and the cells were
incubated for 5 min at 4uC. Either isotypes or autofluorescence
served as controls. Cells were gated on vital cells, indicated by low
7-AAD signals.
Cytotoxicity Assay
A lactate dehydrogenase (LDH)-releasing assay (Roche) was
performed according to the manufacturer’s protocol to assess the
influence of MSCs on CIK cytotoxicity. Fourteen-day-old cCIKs
and control CIKs were incubated with target cells (Wehi 164 S,
fibrosarcoma cell lineage, DSMZ) in 96-well plates at various
effector cell:target cell ratios (1:1 to 50:1). After 4 h, the plates
were centrifuged, and 100 ml of supernatants were transferred to
fresh 96-well plates. Subsequently, an LDH-substrate mixture
(100 ml, content of the kit) containing tetrazolium salt INT was
added to the supernatants. After incubation for 30 min in dark at
room temperature, absorbance was determined at a wavelength of
492 nm against a reference wavelength of 600 nm. Lysis was
calculated using the following equation:
Lysis~
induced target release spontaneousrelease spontaneous release
target maximum release spontaneous release
|100
CFU-F-Assay
In a modified version of the technique originally described by
Kuznetsov et al. [37], 10 million bone marrow cells were
suspended in either 5 ml of normal medium (DMEM low glucose,
10% FCS, and 1% penicillin/streptomycin; all purchased from
Gibco, Invitrogen) or osteogenic medium (normal medium,
supplemented with dexamethasone [1 ml/ml] and ascorbic acid
[50 mg/ml]; purchased from AppliChem, Germany). The medium
was first changed after 72 h and then after every 3–4 days. On day
14, cells were washed with PBS and fixed in ethanol at 4uC for
20 min. Fixed cells were stained with alkaline phosphatase (ALP)
staining solution (Tris, dimethylformamide, naphthol ASBI, and
fast red; all purchased from AppliChem) and photographed. Cells
were then discoloured by incubation with 90% ethanol overnight,
stained with methylene blue (AppliChem), and then were
photographed again.
Statistics
The Mann-Whitney U-test was used to assess statistical
significance. Differences with a p value of ,0.05 were considered
statistically significant. Error indicators reflect SEM (standard
error of the mean).
Results
CIK Proliferation Effects of Coculturing CIKs with MSCs
and Cultivating CIKs in MSC-conditioned Medium
Many strategies for optimizing the culture conditions of CIKs
have been investigated. In this study, the effects of an MSC/CIK
coculture system on CIKs were examined. Seven-day-old CIKs
were cocultured with MSCs for 10 further days (cCIKs).
To investigate the influence of humoral factors, some of the
CIKs were cultured in cell-free MSC supernatants from day 7
onward (mediaCIKs). The influences of potential immune
reactions of CIKs against MSCs were excluded by centrifuging
the supernatants before addition to CIKs.
Cell numbers were determined using the trypan blue method on
days 0, 3, 7, 11, 14, and 17. After day 7 (beginning of coculture),
the number of cCIKs increased from 133 million to 2,515 million
(day 14) and that of mediaCIKs increased from 133 million to 733
million. In the same period, the number of control cells increased
from 133 million to 495 million. After day 14, the absolute cell
numbers of controls, cCIKs, and mediaCIKs decreased (Figure 1).
Effects on Phenotype
For investigating the effects of coculture on CIK phenotype,
controls and cCIKs were harvested on day 14 (after 7 days of
coculture) and analysed using flow cytometry. The results
demonstrated that the phenotypes of controls and cCIKs were
identical (Figure 2). All cells were positive for CD3 and CD45.
CD4 was absent, whereas CD8a was highly expressed on both
cCIKs and controls. Only low signals of CD11b were detectable.
The signals from NK cell markers CD49 and NK1.1 were weak
for controls as well as for cCIKs. Strong CD25 and CD69 signals
reflected an advanced stage of cell activation.
Effects on CIK Vitality
The vitalities of three different cultures from day 14 were
assessed by trypan blue staining and via flow cytometry (7-AAD
staining). Figure 3A presents the vitalities determined using trypan
blue staining. The vitality of cCIKs was 87% and that of controls
was 64% of total cells (p = 0.1). Figure 3B shows the related dot
plots of 7-AAD staining from flow cytometry. Vital cells have low
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Figure 1. Comparison of cytokine-induced killer cell (CIK) proliferation. CIKs were cultivated according to protocol (controls). On day 7,
some of the CIKs were cultivated either with mesenchymal stem cells (cCIKs) or in MSC-conditioned medium (mediaCIKs), and proliferation was
compared with that of controls. After starting the coculture, cCIKs proliferated faster than controls (p,0.05). The mediaCIKs displayed increased
proliferation (p.0.1), too, but proliferation rates did not reach the level of cCIK proliferation.
doi:10.1371/journal.pone.0088115.g001
Figure 2. Comparison of CIK phenotypes. Fluorescence-activated cell sorter (FACS) analyses of control CIKs and cCIKs were performed on day
14. Controls expressed typical CIK markers, including T-cell markers CD3, CD8a, and CD25 and natural killer (NK) cell markers such as CD49, CD69, and
NK1.1. No differences were observed between control CIKs and cCIKs.
doi:10.1371/journal.pone.0088115.g002
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signal intensities, whereas the staining solution passes through the
damaged membranes of non-vital cells, as reflected by high signal
intensities. 80% of cCIKs showed low signal intensities suggestive
of vital cells. Low intensities were seen in 65% of controls, but the
difference was not significant (p = 0.1).
Effects on CIK Cytotoxicity
Cytotoxicity is a crucial variable of CIKs in anti-tumour therapy
applications. An LDH-releasing assay was performed to determine
the cytotoxicity of CIKs against tumour cells (Wehi 164 S).
Figure 4 shows the average lysis rates of controls and cCIKs for
various effector-cell/target-cell ratios. Initially, lysis rates increased
with increasing effector-cell/target-cell ratio, up to a lysis rate of
27% at a ratio of approximately 30:1. Further increases in the
ratios did not increase lysis rates further. No significant differences
were found between controls and cCIKs at any of the tested ratios
(p.0.1).
MSC Characterization
The MSCs used in this study were characterized by their
adherence to plastic surfaces; by their spindle-shaped, fibroblast-
like morphology; by their capability to differentiate in CFU-F-
Assays into osteoblasts; and by phenotypical features. To illustrate
the spindle-shaped, fibroblast-like morphology, we evaluated
MSCs with light microscopy (106 augmentations), and represen-
tative photographs were taken on days 4, 7, 12, and 42. As is
characteristic for MSCs, the cells underwent time-dependent
transitions from thin spindle-shaped cells to wider spindle-shaped
cells to still wider spindle-shaped cells (Figure 5A).
The potential to proliferate in CFUs and differentiate in the
presence of dexamethasone and ascorbic acid into osteoblasts is
shown in Figure 5B, which shows adherent bone marrow cells
growing in colonies. When cultivated in normal medium (without
dexamethasone and ascorbic acid) only a few of the total colonies
that could be observed with nonspecific methylene blue staining
expressed alkaline phosphatase (ALP). In contrast, when cells were
cultivated in osteogenic medium (containing dexamethasone and
ascorbic acid), most of the colonies presented in total colony
staining were simultaneously positive for ALP.
For phenotypical characterization, some of the MSCs were
harvested on day 7 and analysed using flow cytometry. Because
the cocultures started on day 7, the phenotype shown in Figure 6
reflects the phenotype of the MSCs used for the cocultures. MSCs
were negative for CD3, CD31, CD34, and CD90. Positive signals
were detected for CD44, CD73, and CD166, and positive as well
as negative signals were detected for CD45.
Figure 3. Comparison of CIK vitality. Vitalities of control CIKs and cCIKs were assessed on day 14 using two different methods. Part A displays
vitalities determined using trypan blue staining. No significant differences in CIK viability were found at the 0.05 level (p = 0.1). Part B shows
comparisons of CIK vitality, as assessed using 7-AAD staining. No significant differences were found (p = 0.1).
doi:10.1371/journal.pone.0088115.g003
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Phenotype of Adherent Cells after Coculture
When adherent cells were evaluated under light microscope at
the end of coculture, they were found to have lost their typical
spindle-shaped morphology. Surprisingly, the cells looked like
CIKs instead (data not shown). To identify the adherent cells in
the coculture flasks, we harvested these cells at the end of the
coculture and analysed them using flow cytometry for MSC- and
CIK-specific surface markers. The cells were found to express the
surface markers for CIKs, not MSCs (Figure 7).
DiD-labelled MSCs
As shown in Figure 7, adherent cells after coculture displayed
the same phenotypical markers as CIKs and no longer resembled
MSCs. To investigate whether MSCs in coculture had been lysed
Figure 4. Comparison of CIK lysis potential against tumour cells. Lysis rates of control CIKs compared with those of cCIKs against
fibrosarcoma cells (Wehi 164 S) on day 14 for different effector-cell/target-cell ratios. Error indicator represents standard error of the mean. Initially,
lysis rates increased with increasing effector-cell/target-cell ratio up to a lysis rate of 27% at a ratio of approximately 30:1. Further increases in the
ratios did not increase lysis rates further. No significant differences were observed between control CIKs and cCIKs (p.0.1).
doi:10.1371/journal.pone.0088115.g004
Figure 5. MSC characterization. A: MSCs were evaluated under a light microscope and representative photographs were captured on days 4, 7,
12, and 42 of incubation. Cells show typical fibroblast morphology and undergo typical time-dependent transitions among three morphologically
distinct cell types: thin spindle-shaped cells, wider spindle-shaped cells, and still wider spindle-shaped cells. B: Fibroblastic colony-forming unit assays
(CFU-F) were performed for 14 days. Colonies were then stained for ALP and methylene blue. When cultivated in normal medium, only a few colonies
expressed ALP (line 1), whereas nearly all of the colonies stained with methylene blue also showed ALP expression when cultivated in osteogenic
medium (line 2).
doi:10.1371/journal.pone.0088115.g005
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or had changed their phenotype via differentiation or cell fusion,
we performed coculture experiments using DiD-labelled MSCs.
Some DiD-labelled MSCs were harvested and analysed before
starting the coculture (Figure 8, first line). A clearly positive signal
for DiD was measured, indicating successful DiD labelling the
previous day (positive control). Corresponding to the MSC
phenotypes presented in Figure 6 and Figure 7, these cells too
were CD32 and CD252. In contrast, CIKs were CD3+ and
CD25+ and DiD negative (because they were unlabelled).
After 4 h of coculture, adherent cells and suspended cells were
harvested separately, stained for CD3/CD25, and re-analysed
using flow cytometry (see Figure 8, second line). In contrast to the
previous analysis, adherent cells switched from CD32/CD252 to
CD3+/CD25+, and the DiD signal disappeared. Differences
between adherent cells and suspended cells (CIKs) were no longer
detectable. The third line in Figure 8 shows the results of an
analysis carried out after 24 h of coculture and confirms these
results. Adherent cells were DiD negative and positive for CD3
and CD25 and thus resemble the CIK phenotype.
Discussion
We found that CIKs in coculture proliferated within 7 days
with an average growth factor of 18.84, whereas controls
proliferated with an average factor of 3.7 in the same period
(Figure 1). The mechanisms responsible for this increase in
proliferation of cCIKs have not yet been revealed. Four potential
factors are discussed below: cell–cell interactions, humoral factors,
MSC differentiation, and proliferation as a result of immune
reactions against MSCs.
Cell–cell Interactions vs. Humoral Factors
Many studies have reported MSC interactions with lymphocytes
based on cell–cell contact. Various molecules on the surfaces of
human MSCs, such as integrins, intercellular adhesion molecules
(I-CAMs), or lymphocyte function-associated antigen-3 (LFA-3),
have been found to bind to T-lymphocytes and mediate
immunologic interactions [39]. Krampera et al. [40] for instance
reported inhibition of proliferation and cytotoxicity of T-lympho-
cytes stimulated with their specific antigens when cocultured with
MSCs. They further demonstrated that inhibition did not occur
when MSC-conditioned medium was used instead of MSCs or
when the experiments were performed in transwell membrane
systems. Another group reported that MSCs can regulate the
immune response of activated T-lymphocytes via the FAS ligand
(FASL)/FAS-mediated pathway through cell–cell contact [55].
Vellasamy et al. [57] showed inhibition of PHA stimulated T-cells
by MSCs in a dose dependent manner through cell–cell contact.
In contrast, other authors emphasize humoral aspects of
interactions, showing for example, inhibition of proliferation of
activated CD2+ lymphocytes by MSCs in a transwell membrane
system [41]. Antibodies against hepatocyte growth factor and
transforming growth factor b1 could abolish this effect, suggesting
that these mediators may play a role in the observed effects [41].
Spaggiari et al. [34] described indoleamine 2,3-dioxygenase and
prostaglandin E2-mediated suppression of proliferation, cytotox-
icity, and cytokine production of NK cells. Maitra et al. [43]
argued that MSCs do not constitutively secrete these soluble
factors because culture supernatants from MSCs do not suppress
lymphocyte proliferation, whereas cell-free supernatants from
MSC-lymphocytes cocultures do.
Burr et al. [56] describe a more complex interplay between
MSCs and lymphocytes, including cell contact, soluble mediators
(prostaglandin E2 and transforming growth factor b), and indirect
effects via manipulation of other antigen-presenting cells.
However, this study shows significantly increased proliferation
of CIKs when cocultured with MSCs (p,0.05). As MSCs produce
IL-7, IL-12, and IL-15 [42] and as these cytokines are known to
stimulate the proliferation of lymphocytes and CIKs [7,32], it
seems supposable that the stimulating effects of the coculture are
(at least) partly mediated by these (humoral) factors. But no
significant influences on CIK proliferation were observed when
CIKs were cultured in MSC-conditioned medium (p.0.1)
(Figure 1), suggesting that the increased proliferation of cCIKs is
mainly the result of cell contact-dependent mechanisms. However,
only a few experiments with mediaCIKs have been performed
owing to low numbers of MSCs. Further experiments are required
to get more certain statements.
Figure 6. MSC phenotyping. MSCs were harvested and analysed with flow cytometry for a panel of MSC-characterizing markers on day 7. Thus,
the presented phenotype resembles that of MSCs used in the cocultures. MSCs were negative for CD3, CD31, CD34, and CD90. Positive signals were
measured for CD44, CD73, and CD166. Positive as well as negative signals were detected for CD45.
doi:10.1371/journal.pone.0088115.g006
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Differentiation
Aside from cell–cell interactions and humoral factors, differen-
tiation processes may also be responsible for the increased
proliferation of CIKs in coculture. The disappearance of
CD32/CD252 cells from the coculture flasks alone may, for
instance, support this theory. However, several arguments
contradict this conclusion.
In contrast to pluripotent embryonic stem cells, CD342
multipotent mesenchymal stem cells have a more limited
differentiation potential. They can differentiate into osteoblasts,
chondrocytes, adipocytes, and other cell types but not into
lymphocytes that originate from CD34+ haematopoietic stem
cells (HSC) [27,29]. However, some studies concerning murine
MSCs argued that in contrast to human MSCs, murine MSC
populations may include CD34+ cells [44–46].
More recent publications referring to very small embryonic-like
stem cells (VSELs) should be considered as well. This small stem
cell fraction is located in the bone marrow, and these cells express
embryonic stem cell markers and can differentiate into cells of all
three germ layers [47,48]. If VSELs are present among MSCs,
they might differentiate into CIKs and thus increase CIK
numbers.
However, our results do not support differentiation theories, as
shown by the results of our coculture experiments using DiD-
labelled MSCs. In these experiments, DiD+ cells entered the
coculture, and 4 h later, all cells were DiD2. At the same time,
the phenotype switched from CD32/CD252 to CD3+/CD25+,
what is CIK phenotype. The differentiation of all MSCs into
CD3+/CD25+ CIKs seems highly unlikely in such a short period.
Even if this differentiation occurred, the cells should have stayed
DiD+. In fact, they might have lost their DiD labelling as a result
of membrane damage owing to CIK attacks for example, or
thinning as a consequence of rapid proliferation, but the number
of required coincidences for such an event to occur is substantial.
On the other hand, 4 h seem to be an adequate time span for lysis.
Furthermore, the occurrence of immune reactions is strongly
consistent with the disappearance of DiD+ and CD32/CD252
cells. Thus, lysis seems to offer a more plausible explanation.
Figure 7. Comparison phenotypes: CIKs – adherent cells after coculture - MSCs. After 7 days of CIK/MSC coculture (day 14), adherent cells
were harvested separately from suspended cells and analysed using flow cytometry. In addition, 14-day-old MSCs and CIKs were harvested and
analysed for the same markers. Adherent cells after coculture (column in the middle) display the phenotype of CIKs (left column) and differ
considerably from the phenotype expected for MSCs (right column).
doi:10.1371/journal.pone.0088115.g007
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Immune Reactions
Overall, because the cells were derived from various allogeneic
mice, the incidence of immune reactions seems very likely.
Interestingly, MSCs are postulated to be non-immunogenic
[30,33]. In addition, many publications have even shown their
suppressive and antiproliferative effects on T-lymphocytes and NK
cells [17,31,32,49]. These findings are very surprising with regard
to the findings of the present study, wherein we show the
proliferation-stimulating effects of MSCs on a cell population that
combines elements of T-lymphocytes and NK cells. This raises
questions about the possible mechanisms underlying these
observed effects.
In fact, CIKs combine characteristics of both T-lymphocytes
and NK cells, but they are neither. Furthermore, studies have
shown that MSCs are not generally immunosuppressive and
antiproliferative, but multiple factors and pre-conditions must be
taken into account to explain their effects. Le Blanc [31], for
example, reported that MSCs display dose-dependent inhibition of
T-lymphocyte proliferation and that addition of low numbers of
MSCs can even enhance lymphocyte proliferation. Spaggiari et al.
[32] reported that allogeneic MSCs are lysed, not by resting NK
cells but by IL-2-activated NK cells, which is interesting in the
context of the results of the present study, as CIKs are also
stimulated by IL-2. The same group showed that MSCs inhibit the
proliferation of resting NK cells but only partially affect the
proliferation of activated NK cells [34]. Eliopoulos and Fibbe
[35,38] have reported increasing CD8a+ T-lymphocytes, NK
cells, and NKT cell numbers after coinfusion of CD34+
haematopoietic stem cells and allogeneic MSCs in the context of
haematopoietic stem cell transplantation, which is contrary to the
postulated immunosuppressive effects of MSCs and the related
promising expectations of using MSCs in the therapy of GvHD.
Above all, species-dependent distinctions must be taken into
consideration because studies on MSCs concern predominantly
human MSCs and remarkable differences exist among species
[31,50].
In summary, the immunologic interactions of MSCs are
complex and poorly understood. According to current under-
standing, inhibitory as well as stimulatory effects occur side by side.
Cell–cell interactions as well as humoral factors or immune
reactions against MSCs are imaginable causes for the increased
Figure 8. DiD-labelled MSCs. To investigate whether cocultured MSCs were differentiated, we carried out coculture experiments using DiD-
labelled MSCs. Suspended cells (cCIKs) and adherent cells were harvested separately from each other after 4 and 24 h of coculture, stained with anti-
CD3 and anti-CD25, and analysed using flow cytometry. The first line shows the results of flow cytometry analysis just before the addition of CIKs to
the labelled MSCs. Clearly positive DiD signals were seen at the MSCs (positive control). However, CD3 and CD25 were negative, which was expected
for MSCs. The CIKs were not labelled and were therefore DiD negative. As for CIKs characteristic, CD3 and CD25 were positive. The second line shows
the results of FACS analysis of adherent cells and suspended cells after 4 h of coculture. Adherent cells have switched phenotype from CD32/CD252
to CD3+/CD25+. DiD signals of adherent cells have disappeared. Suspended cells were still CD3+/CD25+ and DiD2. The third line (after 24 h)
confirms the results seen after 4 h. Adherent cells showed the phenotype of the suspended cells and were DiD2.
doi:10.1371/journal.pone.0088115.g008
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proliferation rates we observed in this study, whereas differenti-
ation of MSCs to CIKs seems, according to existing data, unlikely.
Effects on Phenotype, Cytotoxicity, and Vitality
For MSCs to be used to improve in vitro yield of CIKs, the
possible impacts on the qualitative characteristics of cCIKs must
be known. We found no evidence for any effects of MSCs on the
phenotype of cCIKs (Figure 2). In addition, cytotoxicity against
the analysed tumour cells (Wehi 164 S) did not seem to be
compromised (Figure 4), which is of particular importance in
terms of use in treating malignant diseases. Interestingly,
coculturing seemed beneficial for vitality (Figure 3); however,
further experiments are required to assess the significance of this
possible benefit in more detail.
Identification of MSCs
The identification of MSCs is not trivial for many reasons.
Different extraction sites, inhomogeneous methods of isolation or
cultivation, varying medium compositions, donor age, and many
other factors [21,23,24] may lead to enrichment of different
subsets of cells, which may also display disparities in differentiation
potential, proliferation rate, or phenotype. Therefore, comparing
MSCs, especially those of different species, often presents
difficulties that are reflected in the ambiguity and even contradic-
tions in the literature on MSCs. Specific markers or assays for the
identification of MSCs, particularly for murine MSCs, still do not
exist. To cope with this lack of tools, we identified the MSCs used
in this study by criteria proposed by the ISCT for human MSCs
but that in addition do consider publications about murine MSCs.
These criteria include: adherence to plastic surfaces [25,26,27,28];
spindle-shaped, fibroblast-like morphology [27,54]; ability to grow
in colonies and differentiate into osteoblasts in CFU-F-Assays
[21,28]; and phenotypical features [15,28,44–46,51–53].
The criterion of adherence to plastic is a result of isolating
MSCs in accordance to the protocol of Dobson [25], which is
fundamentally based on the selection of plastic-adherent cells from
bone marrow cells.
The spindle-shaped, fibroblast-like morphology is demonstrated
in Figure 5A. As has been described by numerous authors [51,54],
a typical time-dependent transition through three morphologically
distinct cell types could be observed when the cells were evaluated
under light microscope: from thin spindle-shaped cells to wider
spindle-shaped cells and to still wider spindle-shaped cells. The
morphology is similar to that of fibroblasts, which is characteristic
of MSCs.
Figure 5B shows the classical colony-growing shape of MSCs
under normal as well as osteogenic differentiation conditions and
the production of ALP when cultivated in osteogenic medium.
The characteristic capability of MSCs to differentiate into
osteoblasts in the presence of dexamethasone and ascorbic acid
also supports the identification of adherent cells used in this study
as MSCs.
Additionally, the identified MSCs were characterized pheno-
typically. In accordance with publications on murine MSCs,
adherent cells were CD32, CD312, CD342, CD44+, CD73+,
and CD166+. Questions may arise concerning CD45 and CD90
because the results of this study show CD45+ as well as a CD452
population and a negative signal for CD90, which is contrary to
the results of numerous authors who have postulated that MSCs
have a CD452 and CD90+ phenotype [17,28,29]. This discrep-
ancy in the literature seems to be due at least partly to differences
between human and murine MSCs. For the most part, studies on
MSCs have focussed on human MSCs, and these cells in fact are
CD452 and CD90+. Even the ISCT criteria for MSCs include
this CD452 and CD90+ phenotype, although these criteria are
strictly for human MSCs [28]. Deeper review of the few and rare
studies on murine MSCs reveals a more distinct understanding
and heterogeneous phenotype. According to Phinney and
colleagues [46], murine MSCs are a very heterogeneous cell
population with many differences even between various mouse
strains and may definitely contain CD45+ cells.
Baddoo and colleagues [45] describe murine MSCs as basically
CD452 but state that plastic-adherent bone marrow cells are
simply a mixture of fibroblastic and haematopoietic cell types.
This group argues that isolation protocols relying only on plastic
adherence of MSCs are insufficient for adequate separation of the
various subsets of murine bone marrow cells. FACS analyses of
these MSCs also revealed CD45+ and CD452 subsets, as
demonstrated in our study. To obtain pure MSC cultures, an
immune-depleting method is proposed instead by the group. In
fact, by immune-depletion isolated murine MSCs did not express
CD45 anymore. Just as well consistent with the findings of our
study, neither the adherent MSCs nor the by immune-depletion
isolated MSCs displayed CD90 on their surfaces. A possible
explanation is delivered by Colter et al. [51], who reported that
CD90 is not expressed on all murine MSCs and that its expression
is dependent on the age and maturation state. Another important
fact is that two different alloantigens occur for CD90: CD90.1
(Thy1.1) and CD90.2 (Thy1.2). The usual commercial antibodies
bind either Thy1.1 or Thy1.2, depending on the respective clone.
They usually do not cross-react, which makes analyses more
complex to some extent. Overall, data about CD90 expression on
murine MSCs are quite rare and inconsistent, and the picture
becomes murkier when different mouse strains or extracting sites
are considered. A study comparing MSCs isolated from bone
marrow and those isolated from amniotic fluid found no Thy1.2+
MSCs in the latter and only 10% Thy1.2+ cells in the former [15].
Huiming and colleagues [52] analysed Thy1.1 on murine MSCs
and detected no positive signals. This result was confirmed by
another group comparing MSCs from different mouse strains with
human MSCs; neither Thy1.1 nor Thy1.2 was found to be
expressed on murine MSCs, but Thy1.1 was expressed on human
MSCs [53].
Beyond these phenotypical considerations, human MSCs are
known to possess enormous proliferation potential in vitro [29]. In
contrast, murine MSCs reportedly have pure in vitro proliferation
potential [45,46,53], which again agrees with the observations
made while cultivating the MSCs for this study (not shown).
However, the bone marrow cells used herein adhered to plastic
surfaces, possessed spindle-shaped morphology, could proliferate
in colonies and differentiate into osteoblasts in the presence of
dexamethasone and ascorbic acid, and displayed a CD32,
CD312, CD342 and CD44+, CD73+, CD166+ phenotype; all
these features match to a large extent with the characteristics of
murine MSCs [44–46,51–53].
Conclusions
CIKs are a promising new tool for anti-tumour therapy.
Because CIKs are quite rare in vivo, many groups have tried to
optimize their in vitro culture yield. This study investigated the
influence of MSCs on the proliferation, phenotype, vitality, and
cytotoxicity of CIK cells. Increased proliferation was demonstrat-
ed, and higher vitalities were measured. No impacts on phenotype
or cytotoxicity were revealed. The increased proliferation seems to
be attributable primarily to interactions resulting from cell–cell
contact. A subordinate influence of humoral factors seems
supposable, but until now - perhaps because of a small number
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of experiments - could not be ascertained with statistical
significance. Because phenotypical MSCs were no longer detect-
able after 4 h of coculture, immune reactions of CIKs against
MSCs appear to be of importance as well. Experiments using DiD-
labelled MSCs suggested that differentiation processes were not
responsible for the observed effects.
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